AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer

Summary

This phase Ib trial studies the side effects and possible benefits of AL101 before surgery in treating patients with notch activated adenoid cystic cancer. AL101 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving AL101 before surgery may help to control adenoid cystic cancer that has a NOTCH pathway activation.

Timeline

Start

2021-09-30

Primary completion

2026-06-16

Completion

2026-06-16

Drugs

Indications